Karolinska Development Ab Stock Quote 0P3C - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

6.50

Bid

0.00

Ask

0.00

Volume

0.00

0.00 Day's Range 0.00

6.50 52 Week Range 6.50

Market Cap

1.739B

Previous Close

6.50

Open

Last Trade

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

36,429

Shares Outstanding

267,522,000

Dividend Yield

PE Ratio

323.38

Earnings Per Share (EPS)

0.02

Revenue

2.01M

Net Profit

5.39M

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Website

www.karolinskadevelopment.com

Headquarters

Solna, Swe

Founded

1970

Karolinska Development Ab is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker 0P3C. The last closing price for Karolinska Development Ab was SEK6.50. Over the last year, Karolinska Development Ab shares have traded in a share price range of SEK 6.50 to SEK 6.50.

Karolinska Development Ab currently has 267,522,000 shares outstanding. The market capitalization of Karolinska Development Ab is SEK1.74 billion. Karolinska Development Ab has a price to earnings ratio (PE ratio) of 323.38.

Karolinska Development’s portfolio company PharmNovo receives EUR 17.5 million from the innovation program EIC Accelerator

Karolinska Development’s portfolio company PharmNovo receives EUR 17.5 million from the innovation program EIC Accelerator STOCKHOLM, SWEDEN – July 16, 2024. Karolinska Development AB (Nasdaq...

Karolinska Development’s portfolio company Umecrine Cognition secures funding for continued clinical development of golexanolone

Karolinska Development’s portfolio company Umecrine Cognition secures funding for continued clinical development of golexanolone STOCKHOLM, SWEDEN – July 10, 2024. Karolinska Development AB...

Karolinska Development’s portfolio company Biosergen gets final approval to test lead candidate BSG005 in patients with invasive fungal infection

Karolinska Development’s portfolio company Biosergen gets final approval to test lead candidate BSG005 in patients with invasive fungal infection STOCKHOLM, Sweden, June 12 2024. Karolinska...

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	DE
4	6.5	6.5	6.5	36429	6.5	DE
12	6.5	6.5	6.5	36429	6.5	DE
26	6.5	6.5	6.5	36429	6.5	DE
52	6.5	6.5	6.5	6119	6.5	DE
156	6.5	6.5	6.5	9366	6.5	DE
260	6.5	6.5	6.5	9505	6.5	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 0.00 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 0.00 (0.00%)	0
AACGATA Creativity Global	$ 0.00 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 0.00 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 0.00 (0.00%)	0
AACGATA Creativity Global	$ 0.00 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 0.00 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 0.00 (0.00%)	0
AACGATA Creativity Global	$ 0.00 (0.00%)	0